Professor Zhong Nanshan was the first respiratory physician in China to be elected to the Chinese Academy of Engineering. His leadership during both the 2003 SARS outbreak and the 2020 COVID-19 pandemic has been credited with saving countless lives. For his contributions, he has received widespread recognition from the United Nations and government leaders around the world. Widely regarded as one of the most prominent international figures in pulmonology of the 21st century, Professor Zhong also served as President of the Chinese Medical Association, the country’s largest professional body for physicians.
Professor Zhong was the first to lead the Asclepius Meditec clinical research team in launching clinical trials. With his guidance and endorsement, numerous physicians and specialists from China’s top 100 hospitals (out of more than 30,000 nationwide) have adopted Asclepius Meditec’s hydrogen–oxygen therapy in basic research and clinical studies across the nine major systems of the human body, particularly in chronic disease management.
The remarks featured in the video were delivered by Professor Zhong at the launch event ofHydrogen for Cancer Control , a published collection of real-world clinical cases documenting hydrogen–oxygen therapy in 82 patients with advanced-stage cancer.